Studies of TGF-β1 signal transduction provided further evidence that low expression of TβRII by breast cancer cells was correlated with enhanced in vivo malignant behaviours both in tumour specimens and a cancer cell line (Gobbi et al, 1999). The gene discussed is TGFBR2; the disease is cancer.